AI Patent Analysis Toolkit
PatentAgility
by KellDann

Examiner Vincent Day Hoang

Appears inactive Last observed office action: June 2020 (73 months ago).

Examiner Vincent Day Hoang appears to be very easy relative to their art unit, group, tech center, and USPTO peers. Their lifetime grant ratio is 60.0%, they average 1.67 office actions per granted patent, and their rejection profile is dominated by §103, with occasional §101 rejections and elevated §112 usage.

Difficulty vs AU Very Easy
Difficulty vs Group Very Easy
Difficulty vs TC Very Easy
Difficulty vs USPTO Very Easy
Average OA / Grant 1.67
Export
Word PDF

Create account to export.

Examiner Details

Observed Examiner Years
2 years (2019-2020)
Tech Center
3700 - Mechanical Engineering, Manufacturing and Products
Group
3780 - Body Treatment, Kinesitherapy, and Exercising

Metrics

Applications Evaluated
35
Granted Applications
21
Non-Granted Applications
14
Avg OA / Grant
1.67
Last OA Observed
June 2020 (73 months ago)
Art Units Seen
3785
Work Groups Seen

Context Comparison

Scope Examiners Lifetime Grant Ratio Avg OA / Grant
This Examiner 1 60.0% 1.67
Art Unit 82 33.9% 1.75
Group 295 42.1% 1.90
Tech Center 2,662 48.9% 2.01
USPTO 16,348 53.5% 1.98

Grant Timeline

0.0% 25.0% 50.0% 75.0% 100.0% 2019 2020
Shaded region marks the last two observed years, where grant outcomes may lag due to recency.
Year Applications Granted Grant Rate
No observed data before 2019; examiner may not yet have been active in the available dataset.
2019 17 7 41.2%
2020 18 14 77.8%
No observed data after 2020; examiner may have gone inactive or moved out of examining work.

21 family-cache-validated grants; 0 OA-only grant signals.

Rejection Timeline

OA # Office Actions § 101 Percentage § 102 Percentage § 103 Percentage § 112 Percentage
1 43 4.7% 2.3% 69.8% 20.9%
2 19 0.0% 15.8% 36.8% 47.4%
3 2 0.0% 0.0% 50.0% 50.0%

§ 101 Yearly Trend

2019: PEG
5.0%
2019
0.0%
2020

Each bar shows the share of this examiner's observed office actions in that year that included a § 101 rejection.